Avapritinib in PDGFRA D842V GIST By LRG Staff|2021-03-30T14:17:27-04:00March 30th, 2021|Global, Video| This video deals with the mechanism of avapritinib in GIST, current outcomes and challenges with PDGFRA D842V mutated GIST. watch replay Related Posts GIST Day of Learning Virtual – Tennessee GIST Day of Learning Virtual – Tennessee May 18th, 2023 European Patient Cancer Coalition Publishes Patient Guide for Cancer Biomarkers European Patient Cancer Coalition Publishes Patient Guide for Cancer Biomarkers January 27th, 2023 Global Advocacy News – SIMPOSIO ONCOLATINO Global Advocacy News – SIMPOSIO ONCOLATINO September 9th, 2022 Life Fest 2022: The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy Life Fest 2022: The Role of Surgery in GIST Treatment/Neoadjuvant & Adjuvant Therapy August 10th, 2022 Life Fest 2022: Management of GIST & Treatment-related Symptoms Life Fest 2022: Management of GIST & Treatment-related Symptoms August 10th, 2022